Predicting dysthyroid optic neuropathy in moderate-to-severe thyroid eye disease: a clinically applicable nomogram. [PDF]
Hu R +22 more
europepmc +1 more source
#1706739 Efficacy of Teprotumumab in Phenotype Type I vs Type II Thyroid Eye Disease [PDF]
Lejla Cukovic +6 more
openalex +1 more source
Mitigating the risks: addressing smoking cessation in thyroid eye disease. [PDF]
Karimi N +6 more
europepmc +1 more source
Transcriptome analysis of orbital tissue in thyroid eye disease uncovers key pathogenic mediators. [PDF]
Hua W +9 more
europepmc +1 more source
Extraocular muscle volume reduction in a patient treated with two courses of teprotumumab for thyroid eye disease. [PDF]
Richkind H +5 more
europepmc +1 more source
High-Throughput Tear Proteomics Reveals Multi-Faceted Signatures of Thyroid Eye Disease. [PDF]
Li R +6 more
europepmc +1 more source
Dissociation of stimulatory effects of cortocotrophin on adrenal corticosterone and protein synthesis following hypophysectomy [PDF]
Kluge, F., Scriba, Peter Christian
core
Efficacy of Transconjunctival Botulinum Toxin Type A Injection for the Treatment of Thyroid Eye Disease-Induced Upper Eyelid Retraction [PDF]
Thanh Nam Nguyen +1 more
openalex +1 more source

